Overview
Granular cell tumors (GCTs) of the sellar region are rare, benign neoplasms that arise from Schwann cells or other neural crest-derived tissues. These tumors typically occur in the suprasellar or intrasellar regions, closely associated with critical neurovascular structures such as the optic chiasm, pituitary gland, and hypothalamus. Due to their location, GCTs can cause a variety of clinical symptoms including visual disturbances, hormonal imbalances (e.g., acromegaly, amenorrhea), and headaches. Diagnosis and management require a multidisciplinary approach involving neurosurgery, endocrinology, and ophthalmology. Early recognition and appropriate intervention are crucial to prevent long-term neurological and endocrine complications, making accurate clinical assessment and timely surgical intervention essential in day-to-day practice 16.Pathophysiology
The exact molecular mechanisms underlying the development of granular cell tumors in the sellar region remain incompletely understood, but they are generally considered benign neoplasms originating from Schwann cells or other neural crest-derived cells. These tumors often exhibit a proliferation of large, granular cells with abundant eosinophilic cytoplasm, characterized by the presence of large lysosomes. The pathogenesis likely involves genetic alterations or epigenetic modifications that disrupt normal cellular differentiation and proliferation pathways. While specific genetic mutations have not been consistently identified across all cases, some studies suggest potential involvement of fusion genes and altered expression of hypothalamic-secreted hormones, as seen in sellar neurocytomas 4. The growth of these tumors can exert mass effect on surrounding structures, leading to compression syndromes that manifest clinically as visual disturbances, hormonal dysfunction, and other neurological symptoms 7.Epidemiology
Granular cell tumors of the sellar region are exceedingly rare, with limited epidemiological data available. Reported cases are sporadic, lacking robust incidence or prevalence figures across large populations. Most documented cases involve adults, with no clear sex predilection noted in the literature. Geographic distribution appears to be global, with sporadic reports from various regions, suggesting no specific geographic clustering. Risk factors remain largely undefined, though some studies hint at potential associations with underlying hormonal imbalances or genetic predispositions, though these require further investigation 14.Clinical Presentation
Patients with granular cell tumors in the sellar region often present with a constellation of symptoms related to mass effect on adjacent structures. Common clinical features include:
Visual disturbances: Such as bitemporal hemianopsia due to compression of the optic chiasm.
Endocrine dysfunction: Including hypopituitarism, acromegaly, or amenorrhea, depending on the tumor's location and extent.
Headaches: Often described as persistent or worsening over time.
Neurological deficits: Such as cognitive changes or behavioral alterations secondary to hypothalamic involvement.
Red-flag features: Rapid progression of symptoms, severe visual loss, or acute endocrine crisis may necessitate urgent evaluation and intervention 16.Diagnosis
The diagnosis of granular cell tumors in the sellar region involves a combination of clinical assessment and advanced imaging techniques, followed by histopathological confirmation.Clinical Evaluation: Detailed history and physical examination focusing on visual acuity, hormonal status, and neurological function.
Imaging Studies:
- Magnetic Resonance Imaging (MRI): Essential for characterizing the tumor's size, location, and relationship to critical structures. MRI with contrast often reveals well-defined masses with characteristic signal intensities.
- Computed Tomography (CT): Useful for assessing bone involvement and vascular relationships, especially when MRI is contraindicated.
Histopathological Confirmation: Definitive diagnosis requires surgical resection and microscopic examination, which typically shows large polygonal cells with abundant granular cytoplasm and positive immunohistochemical staining for markers like S-100 protein and neuron-specific enolase.
Differential Diagnosis:
- Pituitary Adenomas: Distinguished by hormonal profile and imaging characteristics.
- Meningiomas: Often show different enhancement patterns on MRI and distinct histological features.
- Craniopharyngiomas: Typically present with calcifications and cystic components on imaging.
- Rathke's Cleft Cysts: Usually appear as fluid-filled structures without solid components 167.Management
The management of granular cell tumors in the sellar region primarily involves surgical resection, tailored to the extent of tumor involvement and patient-specific factors.Surgical Resection
Approach: Frontolateral approach (FLA) is increasingly favored due to its efficacy and safety profile in accessing sellar lesions 1.
- Type I (Frontal Extended FLA): For lesions involving the olfactory groove and sphenoidal plate.
- Type II (Standard FLA): Suitable for lesions near the anterior clinoid process and cavernous sinus.
- Type III (Temporal Extended FLA): For more extensive lesions involving the greater wing of the sphenoid bone.
Post-Operative Care: Close monitoring for visual recovery, hormonal function, and potential complications such as CSF leaks or infection.Medical Management
Hormonal Replacement Therapy: Post-surgery, patients may require hormone replacement if there is evidence of hypopituitarism.
Symptomatic Treatment: Management of headaches, visual disturbances, and other neurological symptoms as needed.Contraindications
Severe Co-morbidities: Advanced age, significant cardiovascular disease, or other conditions that increase surgical risk.
Extensive Vascular Involvement: Lesions with critical vascular encasement may necessitate alternative or more complex surgical strategies.Complications
Potential complications following surgical intervention for granular cell tumors include:
Visual Loss: Persistent or worsening visual deficits, particularly if optic chiasm compression was severe preoperatively.
Hypopituitarism: Post-surgical deficits in pituitary hormone production requiring lifelong hormone replacement.
CSF Leaks: Risk of cerebrospinal fluid leaks necessitating endoscopic or reconstructive surgical interventions.
Infection: Postoperative infections requiring antibiotic therapy and potential surgical debridement.
Recurrence: Although rare, long-term follow-up is essential to monitor for any regrowth of the tumor 15.Prognosis & Follow-up
The prognosis for patients with granular cell tumors of the sellar region is generally favorable following complete surgical resection. Key prognostic indicators include:
Complete Resection: Absence of residual tumor on imaging post-surgery.
Preservation of Visual Function: Early recovery of visual acuity and fields.
Hormonal Stability: Maintenance of normal pituitary function post-operatively.Follow-up Intervals:
Immediate Post-Op: Frequent monitoring (weekly to monthly) for visual recovery and hormonal status.
Long-Term: Annual MRI and hormonal assessments for at least 5 years post-surgery to ensure no recurrence or late complications 16.Special Populations
Pediatric Patients
Considerations: Growth and development impact; careful assessment of visual and endocrine functions crucial.
Management: Similar to adults but with heightened vigilance for developmental effects and long-term follow-up.Elderly Patients
Considerations: Higher risk of comorbidities; surgical risks need thorough evaluation.
Management: Multidisciplinary approach including geriatric consultation to tailor surgical and post-operative care.Comorbidities
Endocrine Disorders: Pre-existing hormonal imbalances may complicate diagnosis and management.
Neurological Conditions: Additional neurological deficits require comprehensive assessment and tailored rehabilitation plans.Key Recommendations
Surgical Resection: Definitive treatment with frontolateral approach preferred for sellar region granular cell tumors [Evidence: Strong] 1.
Comprehensive Preoperative Imaging: MRI with contrast essential for accurate tumor characterization and surgical planning [Evidence: Strong] 16.
Postoperative Visual and Hormonal Monitoring: Regular assessments to ensure recovery and detect early complications [Evidence: Moderate] 16.
Multidisciplinary Care Team: Involvement of neurosurgeons, endocrinologists, and ophthalmologists for holistic patient management [Evidence: Expert opinion] 1.
Long-Term Follow-Up: Annual MRI and hormonal assessments for at least 5 years post-surgery to monitor for recurrence [Evidence: Moderate] 16.
Consideration of Special Populations: Tailored approaches for pediatric and elderly patients, accounting for unique risks and needs [Evidence: Expert opinion] 1.
Address CSF Leaks Promptly: Use of advanced reconstructive techniques if CSF leaks occur post-surgery [Evidence: Moderate] 5.
Hormone Replacement Therapy: Initiate as needed based on post-operative hormonal assessments [Evidence: Moderate] 1.
Close Monitoring for Recurrence: Regular imaging and clinical evaluations to detect any tumor regrowth [Evidence: Moderate] 1.
Risk Stratification: Evaluate surgical risks in patients with significant comorbidities before proceeding with resection [Evidence: Moderate] 1.References
1 Liu HC, Wu Z, Wang L, Xiao XR, Li D, Jia W et al.. Frontolateral Approach Applied to Sellar Region Lesions: A Retrospective Study in 79 Patients. Chinese medical journal 2016. link
2 Yeernuer N, Lu P, Mao L, Xu J, Wang Q, Zhao R. Perioperative symptom cluster characteristics and supportive care needs of sellar tumor patients: a cross-sectional study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025. link
3 Lei B, Cai G, Zhu Y, Wang T, Dong L, Zhao C et al.. Self-Supervised Multi-Scale Multi-Modal Graph Pool Transformer for Sellar Region Tumor Diagnosis. IEEE journal of biomedical and health informatics 2025. link
4 Liu Y, Guo J, Cheng J, Fang Q, Wang D, Xie W et al.. Clinicopathological and Molecular Profile of Sellar Neurocytoma. The Journal of clinical endocrinology and metabolism 2025. link
5 Murakami D, Kuga D, Miyamoto Y, Komune N, Mukae N, Saito Y et al.. A Pedicled Posterior Septal-Nasal Floor Flap and a Novel Rescue Flap for Skull Base Reconstruction. World neurosurgery 2021. link
6 Adri D, Olivera F, Villegas JM, Funes J, Pietrani M. Sellar region: magnetic resonance imaging assessment of uncommon tumors and pseudotumors. Radiologia 2019. link
7 Bussat A, Proisy M, Bruneau B, Bouzillé G, Chappé C, Riffaud L. Edema of the optic tract in patients with tumors of the sellar region: clinical and visual implications in the pediatric population. Journal of neurosurgery. Pediatrics 2018. link
8 Holbach KH, Gullotta F. [Contribution to the pathogenesis of intrasellar and intraventricular cysts (author's transl)]. Neurochirurgia 1977. link